Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Can Novo’s Oral Semaglutide Shake Up Indian Diabetes Segment?
Jan 24 2022
•
By
Anju Ghangurde
Can oral semaglutide disrupt the Indian market? • Source: Alamy
More from India
More from Focus On Asia